Replimune (REPL) Assets (2018 - 2026)
Replimune (REPL) recorded Assets of $252.45 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 46.2% from $469.51 million a year earlier and down 24.1% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Assets (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune reported Assets of $332.39 million, down 39.7% from FY2025.
- Annual Assets has a five-year compound annual growth rate of -9.4% (FY2021 to FY2026).
- Across earlier fiscal years, Assets came in at $551.33 million in FY2025 (+13.0%), $487.72 million in FY2024 (-24.6%), $646.59 million in FY2023 (+40.2%) and $461.19 million in FY2022 (-15.1%).
- The fiscal Q1 2027 figure is the lowest quarterly Assets since fiscal Q4 2020.
- On a year-over-year basis, Assets has declined for five consecutive quarters, with an average decline of 18.7% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 60.2% in fiscal Q2 2022, against a decline of 46.2% in fiscal Q1 2027 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $332.39 million (Q4 2026), $333.59 million (Q3 2026) and $389.45 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.87 Bn | 1,099.45 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 614.49 Bn | 533.02 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 502.45 Bn | 475.56 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 368.35 Bn | 322.73 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.42 Bn | 262.41 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.95 Bn | 235.64 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.96 Bn | 191.36 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.17 Bn | 165.37 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Replimune | 1.16 Bn | 107.80 Mn | - | 252.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 252.45 Mn |
| Mar 31, 2026 | 332.39 Mn |
| Dec 31, 2025 | 333.59 Mn |
| Sep 30, 2025 | 389.45 Mn |
| Jun 30, 2025 | 469.51 Mn |
| Mar 31, 2025 | 551.33 Mn |
| Dec 31, 2024 | 603.63 Mn |
| Sep 30, 2024 | 498.20 Mn |
| Jun 30, 2024 | 534.97 Mn |
| Mar 31, 2024 | 487.72 Mn |
| Dec 31, 2023 | 532.93 Mn |
| Sep 30, 2023 | 562.40 Mn |
| Jun 30, 2023 | 603.89 Mn |
| Mar 31, 2023 | 646.59 Mn |
| Dec 31, 2022 | 678.55 Mn |
| Sep 30, 2022 | 436.10 Mn |
| Jun 30, 2022 | 459.43 Mn |
| Mar 31, 2022 | 461.19 Mn |
| Dec 31, 2021 | 485.28 Mn |
| Sep 30, 2021 | 503.46 Mn |
API Access
Replimune Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();